Progressive Care Launches Native Remote Patient Monitoring Mobile App .
Progressive Care Launches Native Remote Patient Monitoring Mobile App and Physician Portal to Remotely Manage Chronic and Transitional Care
Adding Progressive Care (RXMD) $0.04 to Watch List.
Adding to Biotech Stock Review 2022 Watch List.
Speculative, Yes. But Pay Down of $2 Million Toxic Note and...
CB Scientific, Inc. (CBSC) Announces FDA 510(k) Submission.
CB Scientific, Inc. Announces FDA 510(k) Submission of Enhanced myCam Cardiac Event Monitor
Updated product to include significant...
Report on Mitesco (MITI): Zacks Issues $0.53 Price Target, a 165% Potential Gain.
LIVE QUOTE
Original Report: Initiating Coverage...
News and Charts on Four Small Cap Telehealth and Remote Health Monitoring Plays.
After Losing $33 Billion in Value, Teladoc Health Snags an Upgrade.
With chances building...
Institutional Analyst, Weekly Newsletter.
- Telehealth Watch List- 2021 Psychedelic Investor Guide out Wednesday.- Report: Ehave Inc (EHVVF) Our Favorite Small Psychedelic Company- Ehave (EHVVF) Announces Inclusion...
Telehealth Watch List.
We Haven't Looked at the Telehealth Watch List for a Spell and we Were Very Surprised at the YTD Performance.
Hapbee’s (HAPB) TV Series, to Air Over Syndicated Television Networks.
New to The Street TV and Hapbee Technologies, Inc. Sign Contract for 12 Part TV Series Across Syndicated Television Networks
Hapbee (HAPB) Adds 18 New Signal Blends in Major Expansion of Its Digital Wellness...
Hapbee now comes bundled with "lifetime blends" and offers an all-access subscription option.
VANCOUVER, BC, Sept. 20, 2021 /PRNewswire/ - Hapbee Technologies,...
Mitesco (MITI) Sets Opening Dates for New Minneapolis Clinics, Additional Sites in Minneapolis and...
MINNEAPOLIS, MN, Sept. 01, 2021 (GLOBE NEWSWIRE) -- via NewMediaWire -- Mitesco, Inc. (OTCQB:MITI) ("Mitesco" or the "Company"), a leading operator of wellness clinics...
Latest article
IA Initiates Analyst Coverage of Principal Solar (Press Release).
Principal Solar, Inc.Mon, March 20, 2023 at 7:30 AM EDT
Institutional Analyst, Inc....
Selling ARK (ARKK) & Buying AXS Short Innovation (SARK) ETF.
Going Short the Market. No Long Dissertation, No Rush. Market Risk Has Appeared, With Minimal Upside, So Time To Act.
We’re Bearish, but we’re up 257% in Provention Bio (PRVB) Today.
And up 416%, from Adding it to 2022 Watch List!
Great way to wake up after a night of...
